Byar Dp
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Brain Metastases and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 5
- Prostate Cancer Diagnosis and Treatment 5
- Oncology 2
- Colorectal Cancer Screening and Detection 1
- Cancer Treatment and Pharmacology 1
- Co-authors
- S Piantadosi (1 shared paper)Odom Gl (1 shared paper)Joseph Ransohoff (1 shared paper)Hunt We (1 shared paper)E Alexander (1 shared paper)John Mealey (1 shared paper)P. Paoletti (1 shared paper)Robertson Jt (1 shared paper)
- Journals
- PubMed (11 papers)
- Partner nations
- United StatesFrance
In The Last Decade
Byar Dp
11 papers receiving 589 citations
Peers
Comparison fields: 5 of 80
- Genetics 265
- Pulmonary and Respiratory Medicine 301
- Neurology 77
- Cancer Research 72
- Statistics and Probability 39
Countries citing papers authored by Byar Dp
This map shows the geographic impact of Byar Dp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byar Dp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byar Dp more than expected).
Fields of papers citing papers by Byar Dp
This network shows the impact of papers produced by Byar Dp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byar Dp. The network helps show where Byar Dp may publish in the future.
Co-authors
The 17 scholars most cited alongside Byar Dp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. | 1983 | 357 |
| 2 | Reconsideration of orchiectomy in the treatment of advanced prostatic carcinoma. | 1977 | 71 |
| 3 | Factorial designs for randomized clinical trials. | 1985 | 68 |
| 4 | Preliminary studies of histologic prognosis in cancer of the prostate. | 1977 | 65 |
| 5 | Treatment of prostatic cancer: studies by the Veterans Administration cooperative urological research group. | 1972 | 50 |
| 6 | VACURG studies of conservative treatment. | 1980 | 20 |
| 7 | The importance and nature of cancer prevention trials. | 1990 | 13 |
| 8 | VACURG studies of post-prostatectomy survival. | 1980 | 13 |
| 9 | A computerized reference laboratory. | 1979 | 2 |
| 10 | Quantification of the effects of preventive measures. | 1990 | 1 |
| 11 | Incidence, mortality, and survival statistics for prostatic cancer. | 1987 | 1 |
About Byar Dp
Byar Dp is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Genetics, Rheumatology and Endocrinology, Diabetes and Metabolism, having authored 11 papers that have together received 661 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Health Systems, Economic Evaluations, Quality of Life (1 paper), Urologic and reproductive health conditions (1 paper), Hormonal and reproductive studies (1 paper), Glioma Diagnosis and Treatment (1 paper), Colorectal Cancer Screening and Detection (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Genetics (265 citations), Pulmonary and Respiratory Medicine (301 citations), Neurology (77 citations), Cancer Research (72 citations) and Statistics and Probability (39 citations). Byar Dp has collaborated with scholars based in United States and France. Frequent co-authors include S Piantadosi, Odom Gl, Joseph Ransohoff, Hunt We, E Alexander, John Mealey, P. Paoletti, Robertson Jt, Ulrich Batzdorf and Shapiro Wr. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.